Scholarlink

Background <p>The global trend of delayed childbearing underscores age-related fertility decline as a critical health issue, driven primarily by the loss of ovarian follicles. Mitochondrial dysfunction and oxidative stress are key pathological factors in this process. SS31, a mitochondria-targeting antioxidant peptide, holds potential for mitigating reproductive aging, though its precise mechanisms in ovarian aging require further elucidation.</p> Methods <p>This preclinical study utilized a naturally aged (10-month-old) female ICR mouse model and a D-galactose-induced senescence model in human KGN granulosa cells. We investigated the protective effects and mechanism of action of SS31 on the ovarian follicle unit.</p> Results <p>SS31 specifically localized to granulosa cell mitochondria. Treatment alleviated oxidative damage-induced apoptosis, improved mitochondrial function (including membrane potential and ATP production), and ameliorated senescence-associated impairment of the granulosa cell-oocyte unit. Mechanistically, SS31 enhanced cellular antioxidant capacity by activating the NRF2/HO-1 signaling pathway.</p> Conclusion <p>This study demonstrates that SS31 preserves ovarian function by improving mitochondrial performance and redox homeostasis via the NRF2/HO-1 axis. These findings provide a solid theoretical and experimental foundation for the potential application of SS31 in delaying ovarian aging and treating related reproductive disorders, such as premature ovarian insufficiency (POI) and polycystic ovary syndrome (PCOS), highlighting its significant translational value.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Dual action of SS31 via NRF2/HO-1: countering oxidative stress and metabolic dysfunction in ovarian aging

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月17日

查看全文
  • Guohui Zhang,
  • Xinrong Du,
  • Yuhong Zhao,
  • Weiwei Zhi,
  • Li Wang,
  • Xia Bai,
  • Libing He,
  • Hong Xie,
  • Jun Liu,
  • Changli Han,
  • Weixin Liu

摘要

Background

The global trend of delayed childbearing underscores age-related fertility decline as a critical health issue, driven primarily by the loss of ovarian follicles. Mitochondrial dysfunction and oxidative stress are key pathological factors in this process. SS31, a mitochondria-targeting antioxidant peptide, holds potential for mitigating reproductive aging, though its precise mechanisms in ovarian aging require further elucidation.

Methods

This preclinical study utilized a naturally aged (10-month-old) female ICR mouse model and a D-galactose-induced senescence model in human KGN granulosa cells. We investigated the protective effects and mechanism of action of SS31 on the ovarian follicle unit.

Results

SS31 specifically localized to granulosa cell mitochondria. Treatment alleviated oxidative damage-induced apoptosis, improved mitochondrial function (including membrane potential and ATP production), and ameliorated senescence-associated impairment of the granulosa cell-oocyte unit. Mechanistically, SS31 enhanced cellular antioxidant capacity by activating the NRF2/HO-1 signaling pathway.

Conclusion

This study demonstrates that SS31 preserves ovarian function by improving mitochondrial performance and redox homeostasis via the NRF2/HO-1 axis. These findings provide a solid theoretical and experimental foundation for the potential application of SS31 in delaying ovarian aging and treating related reproductive disorders, such as premature ovarian insufficiency (POI) and polycystic ovary syndrome (PCOS), highlighting its significant translational value.

Graphical Abstract